Patents, Grants & Awards
US Patents
US Patents
Cytopeutics is a Malaysian stem cell company granted with several USA Patents for acute stroke, diabetes and macular oedema treatment with cell-based composition, as well as local patents for treatment involving heart, stroke, diabetes, autoimmune disease, critical limb ischemia and eye disease.
- Acute Stroke [No. 10,278,993]
- Diabetes [No.11,052,119]
- Vernal Keratoconjunctivitis [NO. 10,828,332]
US Patent for Acute Stroke
No. 10,278,993
US Patent for Diabetes
No. 11,052,119
US Patent for Vernal Keratoconjunctivitis
No. 10,828,332
Malaysia Patents
Malaysia Patent for Heart
No. MY- 171690-A
Malaysia Patent for Stroke
No. MY-173966-A
Malaysia Patent for Diabetes
No. MY-171193-A
Malaysia Patent for Macular Oedema
No. MY-171311-A
Malaysia Patent for Vernal Keratoconjunctivitis
No. MY- 173386-A
Credentials
cGMP
(Ministry of Health Malaysia)
IPO Award Finalist
Syariah Compliant
Awards
Malaysia Health and Wellness Brand Awards 2017 – 2019
Endorsed by Ministry of Health, Malaysia
Best Brands in Biotechnology Cell-Based Research & Treatment 2015-2016
by Brand Laureate
Medical Technology – Health & Beauty Awards 2015-2016
by Long Life Magazine
SME 100 Awards 2015 Fast Moving Companies
by SME & Entrepreneurship Magazine
Malaysia Health and wellness brand awards 2017/2018/2019
Endorsed by Ministry of Health, Malaysia
BrandLaureate
Best brand in biotechnology cell-based research & treatment 2015-2016
Long Life Magazine
Health and Beauty Awards 2015-2016
SME100 Awards
Fast moving companies